MannKind
Patents, Design & Utilities

Last updated:

List of all MannKind patents 85 in total

Status Patent
Grant
Utility: High capacity diketopiperazine microparticles and methods External link
Filling date: 26 Sep 2025 Issue date: 6 Sep 2022
Application
Utility: Compositions of Clofazimine, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods Comprising Them External link
Filling date: 26 Sep 2025 Issue date: 25 Aug 2022
Grant
Utility: Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic .alpha.-N-protected amino ester External link
Filling date: 26 Sep 2025 Issue date: 31 May 2022
Application
Utility: DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY External link
Filling date: 26 Sep 2025 Issue date: 19 May 2022
Application
Utility: INHALED IMATINIB FOR PULMONARY HYPERTENSION External link
Filling date: 26 Sep 2025 Issue date: 19 May 2022
Grant
Utility: Inhalable dry powder pharmaceutical composition External link
Filling date: 26 Sep 2025 Issue date: 19 Apr 2022
Grant
Utility: Catalysis of diketopiperazine synthesis External link
Filling date: 26 Sep 2025 Issue date: 5 Apr 2022
Application
Utility: DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY External link
Filling date: 26 Sep 2025 Issue date: 17 Feb 2022
Application
Utility: Microcrystalline Diketopiperazine Compositions and Methods External link
Filling date: 26 Sep 2025 Issue date: 17 Feb 2022
Grant
Utility: Dry powder inhaler and system for drug delivery External link
Filling date: 26 Sep 2025 Issue date: 8 Feb 2022
Application
Utility: Compositions of Bedaquiline, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them External link
Filling date: 26 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: PRODRUGS OF TREPROSTINIL External link
Filling date: 26 Sep 2025 Issue date: 9 Dec 2021
Grant
Utility: Microcrystalline diketopiperazine compositions and methods External link
Filling date: 26 Sep 2025 Issue date: 7 Dec 2021
Grant
Utility: Dry powder inhaler and system for drug delivery External link
Filling date: 26 Sep 2025 Issue date: 30 Nov 2021
Application
Utility: REACTOR FOR PRODUCING PHARMACEUTICAL PARTICLES IN A PRECIPITATION PROCESS External link
Filling date: 26 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: COMPOSITION AND METHOD FOR REDUCING HYPOGLYCEMIA EVENTS IN DIABETES TREATMENT External link
Filling date: 26 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: APPARATUS, SYSTEM AND METHOD FOR DETECTING AND MONITORING INHALATIONS External link
Filling date: 26 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES External link
Filling date: 26 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: APPARATUS AND METHOD FOR CRYOGRANULATING A PHARMACEUTICAL COMPOSITION External link
Filling date: 26 Sep 2025 Issue date: 21 Oct 2021
Grant
Utility: Composition and method for reducing hypoglycemia events in diabetes treatment External link
Filling date: 26 Sep 2025 Issue date: 7 Sep 2021
Grant
Utility: Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces External link
Filling date: 26 Sep 2025 Issue date: 31 Aug 2021
Grant
Utility: Reactor for producing pharmaceutical particles in a precipitation process External link
Filling date: 26 Sep 2025 Issue date: 31 Aug 2021
Application
Utility: METHOD AND COMPOSITION FOR TREATING OBESITY External link
Filling date: 26 Sep 2025 Issue date: 26 Aug 2021
Application
Utility: DRY POWDER DRUG DELIVERY SYSTEM External link
Filling date: 26 Sep 2025 Issue date: 12 Aug 2021
Application
Utility: HEAT-STABLE DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS External link
Filling date: 26 Sep 2025 Issue date: 12 Aug 2021
Application
Utility: Use of Ultrarapid Acting Insulin External link
Filling date: 26 Sep 2025 Issue date: 12 Aug 2021
Grant
Utility: Apparatus and method for cryogranulating a pharmaceutical composition External link
Filling date: 26 Sep 2025 Issue date: 3 Aug 2021
Grant
Utility: Heat-stable dry powder pharmaceutical compositions and methods External link
Filling date: 26 Sep 2025 Issue date: 25 May 2021
Grant
Utility: Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents External link
Filling date: 26 Sep 2025 Issue date: 25 May 2021
Grant
Utility: Use of ultrarapid acting insulin External link
Filling date: 26 Sep 2025 Issue date: 25 May 2021
Application
Utility: DRY POWDER INHALER External link
Filling date: 26 Sep 2025 Issue date: 20 May 2021
Application
Utility: Diketopiperazine salts for drug delivery and related methods External link
Filling date: 26 Sep 2025 Issue date: 13 May 2021
Application
Utility: METHOD OF TREATING DIABETES TYPE 2 BY ADMINISTERING ULTRARAPID ACTING INSULIN External link
Filling date: 26 Sep 2025 Issue date: 13 May 2021
Application
Utility: Methods for the synthesis of activated ethylfumarates and their use as intermediates External link
Filling date: 26 Sep 2025 Issue date: 22 Apr 2021
Application
Utility: FORMATION OF N-PROTECTED 3,6-BIS-(4-AMINOBUTYL)-2,5-DIKETOPIPERAZINE THROUGH A CYCLIC ALPHA-N-PROTECTED AMINO ESTER External link
Filling date: 26 Sep 2025 Issue date: 15 Apr 2021
Grant
Utility: Diketopiperazine salts for drug delivery and related methods External link
Filling date: 26 Sep 2025 Issue date: 9 Feb 2021
Application
Utility: METHOD AND COMPOSITION FOR ADMINISTERING PROSTAGLANDINS External link
Filling date: 26 Sep 2025 Issue date: 31 Dec 2020
Application
Utility: Use of Ultrarapid Acting Insulin External link
Filling date: 26 Sep 2025 Issue date: 24 Dec 2020
Grant
Utility: Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic .alpha.-N-protected amino ester External link
Filling date: 26 Sep 2025 Issue date: 22 Dec 2020
Grant
Utility: Methods for the synthesis of activated ethylfumarates and their use as intermediates External link
Filling date: 26 Sep 2025 Issue date: 8 Dec 2020
Grant
Utility: Method of treating diabetes type 2 by administering ultrarapid acting insulin External link
Filling date: 26 Sep 2025 Issue date: 8 Dec 2020
Application
Utility: Diketopiperazine Microparticles with Defined Specific Surface Areas External link
Filling date: 26 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY External link
Filling date: 26 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: Microcrystalline Diketopiperazine Compositions and Methods External link
Filling date: 26 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: DRY POWDER DRUG DELIVERY SYSTEM AND METHODS External link
Filling date: 26 Sep 2025 Issue date: 29 Oct 2020
Grant
Utility: Use of ultrarapid acting insulin External link
Filling date: 26 Sep 2025 Issue date: 15 Sep 2020
Grant
Utility: Diketopiperazine microparticles with defined specific surface areas External link
Filling date: 26 Sep 2025 Issue date: 15 Sep 2020
Grant
Utility: Dry powder inhaler and system for drug delivery External link
Filling date: 26 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Microcrystalline diketopiperazine compositions and methods External link
Filling date: 26 Sep 2025 Issue date: 18 Aug 2020
Grant
Utility: Dry powder drug delivery system and methods External link
Filling date: 26 Sep 2025 Issue date: 18 Aug 2020

Showing 1 to 50 of 85 patents.